Literature DB >> 1917253

The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis.

M Smallman-Raynor1, A Cliff.   

Abstract

Geographically-related computer databases on the global incidence of HIV-1 and HIV-2 infection are being maintained in the Department of Geography at the University of Cambridge, England. Using the information they contain, the original geographical heartlands of HIV-2 infection are identified as former Portuguese and French colonies in West and South Central Africa. The same databases permit the reconstruction of the diffusion corridors by which the virus is spreading from these heartlands into Europe. The reconstruction shows that, as a result of traditional links with their former colonies, the main areas of infection in Europe are Portugal and France. These countries have subsequently acted as diffusion nodes for the spread of the virus to other parts of Europe. The patterns of spread thus differ fundamentally from those by which HIV-1 infection arrived in and is moving through Europe.

Entities:  

Mesh:

Year:  1991        PMID: 1917253     DOI: 10.1093/ije/20.2.480

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Research challenges to the study of HIV/AIDS among migrant and immigrant Hispanic populations in the United States.

Authors:  Sherry Deren; Michele Shedlin; Carlos U Decena; Milton Mino
Journal:  J Urban Health       Date:  2005-06       Impact factor: 3.671

2.  An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.

Authors:  F Damond; A Benard; Claudia Balotta; Jürg Böni; Matthew Cotten; Vitor Duque; Bridget Ferns; Jeremy Garson; Perpetua Gomes; Fátima Gonçalves; Geoffrey Gottlieb; Bernd Kupfer; Jean Ruelle; Berta Rodes; Vicente Soriano; Mark Wainberg; Audrey Taieb; Sophie Matheron; Genevieve Chene; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

3.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

5.  Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.

Authors:  Florence Damond; Antoine Benard; Jean Ruelle; Abraham Alabi; Bernd Kupfer; Perpetua Gomes; Berta Rodes; Jan Albert; Jürg Böni; Jeremy Garson; Bridget Ferns; Sophie Matheron; Geneviève Chene; Françoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

6.  Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group.

Authors:  V Soriano; M Gutiérrez; E Caballero; G Cilla; J L Fernández; A Aguilera; C Tuset; F Dronda; A M Martín; E Carballo; I López; J González-Lahoz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

7.  Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.

Authors:  Kevin Peterson; Sabelle Jallow; Sarah L Rowland-Jones; Thushan I de Silva
Journal:  AIDS Res Treat       Date:  2011-02-09

8.  Prevalence of HIV among blood donors in a tertiary care centre of north India.

Authors:  R N Makroo; Mohit Chowdhry; Aakanksha Bhatia; Bhavna Arora; N L Rosamma
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.